An overview of antithrombotic therapy guidelines.
Lackner
T E
TE
D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D006801:Humans; D015912:Thrombolytic Therapy / Q000451:nursing*
D005343:Fibrinolytic Agents